Markus Naumann
Hat mitgewirkt an:
-
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis
-
Immunogenicity of botulinum toxins
-
Transdermal rotigotine for the perioperative management of Parkinson’s disease
-
Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): development, insights, and impact